Market Overview

UPDATE: BTIG Initiates Rite Aid with PT of $2.25 on Demographic Trends

Share:
Related RAD
5 Consumer Staples Stocks Trading Below 1.0x Sales, 12.0x Earnings
Benzinga's Top Downgrades
CVS Health's Q2 Earnings, Sales Growth Seen Slowing (Investor's Business Daily)

BTIG initiated coverage on Rite Aid (NYSE: RAD) with a $2.25 price target.

BTIG commented, "Rite Aid operates in a sector that stands to benefit from demographic trends and potentially from legislative undertakings as well. The trends are well-known and easily identifiable: the US population is aging, and the post-Second World War cohort, which is disproportionately large, is moving into the 65+ category. That category, in turn, is an increasingly long-lived customer, an increasingly prescription-intensive customer and an increasingly value-focused customer. Add to this the closing of the “donut hole” in Medicare Part D – a broadly popular policy initiative – and the stage is set for an enduring trend of incremental growth."

Rite Aid closed at $1.14 on Wednesday.

Latest Ratings for RAD

DateFirmActionFromTo
Jul 2015Raymond JamesDowngradesOutperformMarket Perform
Jun 2015Credit SuisseReinstatesOutperform
May 2015Mizuho SecuritiesInitiates Coverage onBuy

View More Analyst Ratings for RAD
View the Latest Analyst Ratings

Posted-In: btigAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (RAD)

Get Benzinga's Newsletters